Shopping Cart
- Remove All
- Your shopping cart is currently empty
SKF38393 hydrobromide is the salt form of SKF38393.SKF38393 is a dopamine D1 receptor agonist that increases the expression of Shati/Nat8L mRNA in the NAc of mice; increases the frequency of 5-hydroxytryptamine and n -methyl- D -aspartate-induced locomotion-associated ruptures in astrocytes; can mimic the dopamine-induced inhibition of colonic motility in mice; can promote locust swarming
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $41 | In Stock | |
5 mg | $89 | In Stock | |
10 mg | $128 | In Stock | |
25 mg | $259 | In Stock | |
50 mg | $383 | In Stock | |
100 mg | $569 | In Stock | |
200 mg | $816 | In Stock |
Description | SKF38393 hydrobromide is the salt form of SKF38393.SKF38393 is a dopamine D1 receptor agonist that increases the expression of Shati/Nat8L mRNA in the NAc of mice; increases the frequency of 5-hydroxytryptamine and n -methyl- D -aspartate-induced locomotion-associated ruptures in astrocytes; can mimic the dopamine-induced inhibition of colonic motility in mice; can promote locust swarming |
Targets&IC50 | D1 receptor:110 nM |
In vitro | Methods: To assess the role of dopamine receptor subtypes in the initiation of behavioral sensitization to cocaine, the partial D1 agonist SKF-38393 (0.01-1.0 μg/side), the D2/3 agonist quinpirole (0.1-1.0 μg/side), or saline was infused once daily into the ventral tegmental area (VTA) or nucleus accumbens shell over 3 days. Results: 1.0 μg/side SKF-38393 infusion into the nucleus accumbens shell produced significant behavioral hyperactivity after both the first and last daily infusions, with no significant differences in behavioral responses between days; repeated administration of SKF-38393 into the VTA resulted in sensitization to the locomotor activating effects of cocaine.[6] |
In vivo | Methods: To assess the role of dopamine receptor subtypes in the initiation of behavioral sensitization to cocaine, the partial D1 agonist SKF38393 hydrobromide (0.01-1.0 μg/side), the D2/3 agonist quinpirole (0.1-1.0 μg/side), or saline was infused once daily into the ventral tegmental area (VTA) or nucleus accumbens shell over 3 days. Results: 1.0 μg/side SKF38393 hydrobromide infusion into the nucleus accumbens shell produced significant behavioral hyperactivity after both the first and last daily infusions, with no significant differences in behavioral responses between days; repeated administration of SKF38393 hydrobromide into the VTA resulted in sensitization to the locomotor activating effects of cocaine.[1] |
Alias | SKF 38393 hydrobromide |
Molecular Weight | 336.22 |
Formula | C16H18BrNO2 |
Cas No. | 20012-10-6 |
Smiles | Br.OC=1C=C2C(=CC1O)C(C=3C=CC=CC3)CNCC2 |
Relative Density. | no data available |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: 10 mg/mL (29.74 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.